Peter Hollander

Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Abdulla, Maysaa; Sundström, Christer; Lindskog, Cecilia; Hollander, Peter

Part of Biomolecules, 2023

• DOI for Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases
• Download full text (pdf) of Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

Hellbacher, Erik; Sundström, Christer; Molin, Daniel; Baecklund, Eva et al.

Part of Cancers, 2022

• DOI for Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity
• Download full text (pdf) of Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients

Paulsen, Karin; Marincevic, Millaray; Cavelier, Lucia; Hollander, Peter et al.

Part of Diagnostics, 2022

• DOI for LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients
• Download full text (pdf) of LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients

Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Abdulla, Maysaa; Hollander, Peter; Lindskog, Cecilia; Sundström, Christer et al.

Part of Acta Oncologica, p. 824-829, 2022

• DOI for Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Checkpoint CD47 expression in classical Hodgkin lymphoma

Gholiha, Alex Reza; Hollander, Peter; Löf, Liza; Glimelius, Ingrid et al.

Part of British Journal of Haematology, p. 580-589, 2022

• DOI for Checkpoint CD47 expression in classical Hodgkin lymphoma
• Download full text (pdf) of Checkpoint CD47 expression in classical Hodgkin lymphoma

Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

Gholiha, Alex R.; Hollander, Peter; Löf, Liza; Larsson, Anders et al.

Part of Cancers, 2022

• DOI for Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue
• Download full text (pdf) of Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors

Rodrigues, Joana M.; Nikkarinen, Anna; Hollander, Peter; Weibull, Caroline E. et al.

Part of British Journal of Haematology, p. 520-531, 2021

• DOI for Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors
• Download full text (pdf) of Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors

Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies

Sundström, Christer; Hollander, Peter

Part of Immunobiology, 2021

• DOI for Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies
• Download full text (pdf) of Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies

Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Gholiha, Alex R.; Hollander, Peter; Glimelius, Ingrid; Hedström, Gustaf et al.

Part of Blood Advances, p. 1671-1681, 2021

• DOI for Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden

Sima, Andreea; Hollander, Peter; Baecklund, Eva; Smedby, Karin E. et al.

Part of British Journal of Haematology, p. 568-579, 2021

• DOI for Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden
• Download full text (pdf) of Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden

PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Abdulla, Maysaa; Alexsson, Andrei; Sundström, Christer; Ladenvall, Claes et al.

Part of Acta Oncologica, p. 531-538, 2021

• DOI for PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
• Download full text (pdf) of PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Amini, Rose-Marie; Ljungström, Viktor; Abdulla, Maysaa; Cavelier, Lucia et al.

Part of American Journal of Hematology, 2020

• DOI for Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
• Download full text (pdf) of Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma

Hollander, Peter; Ginman, Beatrice; Molin, Daniel; Enblad, Gunilla et al.

Part of Immunobiology, 2020

• DOI for Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma
• Download full text (pdf) of Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma

Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma

Abdulla, Maysaa; Guglielmo, Priscilla; Hollander, Peter; Åström, Gunnar et al.

Part of European Journal of Haematology, p. 207-213, 2020

• DOI for Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma
• Download full text (pdf) of Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma

Clonal hematopoiesis of indeterminate potential in high grade B-cell lymphomas: clinicobiological associations and further insight with single-cell multiomics analysis

Hesselager, Caroline; Hollander, Peter; Pettersson, Emma; Enblad, Gunilla et al.

Part of Blood Cancer Journal, 2026

• DOI for Clonal hematopoiesis of indeterminate potential in high grade B-cell lymphomas: clinicobiological associations and further insight with single-cell multiomics analysis
• Download full text (pdf) of Clonal hematopoiesis of indeterminate potential in high grade B-cell lymphomas: clinicobiological associations and further insight with single-cell multiomics analysis

Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases

Rostgaard, Klaus; Hamilton-Dutoit, Stephen; Lauridsen, Kristina L.; Ottander, Lisa et al.

Part of International Journal of Cancer, p. 2629-2640, 2026

• DOI for Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases
• Download full text (pdf) of Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases

Accumulation of high-risk genetic features after chemoimmunotherapy: A longitudinal study in mantle cell lymphoma

Nikkarinen, Anna; Almlöf, Jonas; Österroos, Albin; Ladenvall, Claes et al.

Part of Leukemia, p. 681-684, 2026

• DOI for Accumulation of high-risk genetic features after chemoimmunotherapy: A longitudinal study in mantle cell lymphoma

scFFPE-ATAC enables high-throughput single cell chromatin accessibility profiling in formalin-fixed paraffin-embedded samples

Yadav, Ram Prakash; Xing, Pengwei; Zhao, Miao; Hollander, Peter et al.

Part of Nature Communications, 2025

• DOI for scFFPE-ATAC enables high-throughput single cell chromatin accessibility profiling in formalin-fixed paraffin-embedded samples
• Download full text (pdf) of scFFPE-ATAC enables high-throughput single cell chromatin accessibility profiling in formalin-fixed paraffin-embedded samples

CD163⁺ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression

de Matos Rodrigues, Joana; Lokhande, Lavanya; Olsson, Lina M.; Hassan, May et al.

Part of Blood Advances, p. 4370-4385, 2024

• DOI for CD163⁺ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression
• Download full text (pdf) of CD163⁺ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression

Clonal hematopoiesis of indeterminate potential in high grade B-cell lymphomas: clinicobiological associations and further insight with single-cell multiomics analysis

Hesselager, Caroline; Hollander, Peter; Pettersson, Emma; Enblad, Gunilla et al.

Part of Blood Cancer Journal, 2026

• DOI for Clonal hematopoiesis of indeterminate potential in high grade B-cell lymphomas: clinicobiological associations and further insight with single-cell multiomics analysis
• Download full text (pdf) of Clonal hematopoiesis of indeterminate potential in high grade B-cell lymphomas: clinicobiological associations and further insight with single-cell multiomics analysis

Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases

Rostgaard, Klaus; Hamilton-Dutoit, Stephen; Lauridsen, Kristina L.; Ottander, Lisa et al.

Part of International Journal of Cancer, p. 2629-2640, 2026

• DOI for Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases
• Download full text (pdf) of Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases

Accumulation of high-risk genetic features after chemoimmunotherapy: A longitudinal study in mantle cell lymphoma

Nikkarinen, Anna; Almlöf, Jonas; Österroos, Albin; Ladenvall, Claes et al.

Part of Leukemia, p. 681-684, 2026

• DOI for Accumulation of high-risk genetic features after chemoimmunotherapy: A longitudinal study in mantle cell lymphoma

scFFPE-ATAC enables high-throughput single cell chromatin accessibility profiling in formalin-fixed paraffin-embedded samples

Yadav, Ram Prakash; Xing, Pengwei; Zhao, Miao; Hollander, Peter et al.

Part of Nature Communications, 2025

• DOI for scFFPE-ATAC enables high-throughput single cell chromatin accessibility profiling in formalin-fixed paraffin-embedded samples
• Download full text (pdf) of scFFPE-ATAC enables high-throughput single cell chromatin accessibility profiling in formalin-fixed paraffin-embedded samples

CD163⁺ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression

de Matos Rodrigues, Joana; Lokhande, Lavanya; Olsson, Lina M.; Hassan, May et al.

Part of Blood Advances, p. 4370-4385, 2024

• DOI for CD163⁺ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression
• Download full text (pdf) of CD163⁺ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression

MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53: a Nordic Lymphoma Group study

Rodrigues, Joana M.; Hollander, Peter; Schmidt, Lina; Gkika, Eirinaios et al.

Part of Haematologica, p. 1171-1183, 2024

• DOI for MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53: a Nordic Lymphoma Group study
• Download full text (pdf) of MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53: a Nordic Lymphoma Group study

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma

Nikkarinen, Anna; Lokhande, Lavanya; Amini, Rose-Marie; Jerkeman, Mats et al.

Part of Blood Advances, p. 5304-5313, 2023

• DOI for Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma

Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Abdulla, Maysaa; Sundström, Christer; Lindskog, Cecilia; Hollander, Peter

Part of Biomolecules, 2023

• DOI for Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases
• Download full text (pdf) of Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

Hellbacher, Erik; Sundström, Christer; Molin, Daniel; Baecklund, Eva et al.

Part of Cancers, 2022

• DOI for Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity
• Download full text (pdf) of Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients

Paulsen, Karin; Marincevic, Millaray; Cavelier, Lucia; Hollander, Peter et al.

Part of Diagnostics, 2022

• DOI for LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients
• Download full text (pdf) of LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients

Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Abdulla, Maysaa; Hollander, Peter; Lindskog, Cecilia; Sundström, Christer et al.

Part of Acta Oncologica, p. 824-829, 2022

• DOI for Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Checkpoint CD47 expression in classical Hodgkin lymphoma

Gholiha, Alex Reza; Hollander, Peter; Löf, Liza; Glimelius, Ingrid et al.

Part of British Journal of Haematology, p. 580-589, 2022

• DOI for Checkpoint CD47 expression in classical Hodgkin lymphoma
• Download full text (pdf) of Checkpoint CD47 expression in classical Hodgkin lymphoma

Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

Gholiha, Alex R.; Hollander, Peter; Löf, Liza; Larsson, Anders et al.

Part of Cancers, 2022

• DOI for Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue
• Download full text (pdf) of Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors

Rodrigues, Joana M.; Nikkarinen, Anna; Hollander, Peter; Weibull, Caroline E. et al.

Part of British Journal of Haematology, p. 520-531, 2021

• DOI for Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors
• Download full text (pdf) of Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors

Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies

Sundström, Christer; Hollander, Peter

Part of Immunobiology, 2021

• DOI for Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies
• Download full text (pdf) of Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies

Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Gholiha, Alex R.; Hollander, Peter; Glimelius, Ingrid; Hedström, Gustaf et al.

Part of Blood Advances, p. 1671-1681, 2021

• DOI for Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden

Sima, Andreea; Hollander, Peter; Baecklund, Eva; Smedby, Karin E. et al.

Part of British Journal of Haematology, p. 568-579, 2021

• DOI for Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden
• Download full text (pdf) of Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden

PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Abdulla, Maysaa; Alexsson, Andrei; Sundström, Christer; Ladenvall, Claes et al.

Part of Acta Oncologica, p. 531-538, 2021

• DOI for PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
• Download full text (pdf) of PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma

Abdulla, Maysaa; Hollander, Peter; Pandzic, Tatjana; Mansouri, Larry et al.

Part of American Journal of Hematology, p. 57-67, 2020

• DOI for Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma
• Download full text (pdf) of Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma

CD30 expression and survival in posttransplant lymphoproliferative disorders

Kinch, Amelie; Amini, Rose-Marie; Hollander, Peter; Molin, Daniel et al.

Part of Acta Oncologica, p. 673-680, 2020

• DOI for CD30 expression and survival in posttransplant lymphoproliferative disorders
• Download full text (pdf) of CD30 expression and survival in posttransplant lymphoproliferative disorders

Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Amini, Rose-Marie; Ljungström, Viktor; Abdulla, Maysaa; Cavelier, Lucia et al.

Part of American Journal of Hematology, 2020

• DOI for Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
• Download full text (pdf) of Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma

Hollander, Peter; Ginman, Beatrice; Molin, Daniel; Enblad, Gunilla et al.

Part of Immunobiology, 2020

• DOI for Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma
• Download full text (pdf) of Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma

Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma

Abdulla, Maysaa; Guglielmo, Priscilla; Hollander, Peter; Åström, Gunnar et al.

Part of European Journal of Haematology, p. 207-213, 2020

• DOI for Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma
• Download full text (pdf) of Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma

High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

Gholiha, Alex R.; Hollander, Peter; Hedström, Gustaf; Sundström, Christer et al.

Part of British Journal of Haematology, p. 192-201, 2019

• DOI for High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

Amini, Rose-Marie; Enblad, Gunilla; Hollander, Peter; Laszlo, S. et al.

Part of BMC Cancer, 2019

• DOI for Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
• Download full text (pdf) of Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma

Hollander, Peter; Amini, Rose-Marie; Ginman, Beatrice; Molin, Daniel et al.

Part of PLOS ONE, 2018

• DOI for Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma
• Download full text (pdf) of Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma

An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome

Hollander, Peter; Rostgaard, Klaus; Ekström-Smedby, Karin; Molin, Daniel et al.

Part of European Journal of Haematology, p. 88-97, 2018

• DOI for An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome
• Download full text (pdf) of An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome

High proportions of PD-1⁺ and PD-L1⁺ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

Hollander, Peter; Kamper, Peter; Smedby, Karin Ekstrom; Enblad, Gunilla et al.

Part of Blood Advances, p. 1427-1439, 2017

• DOI for High proportions of PD-1⁺ and PD-L1⁺ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

High Expression Of Programmed Cell Death Receptor 1 In The Tumor Microenvironment Is Associated With Inferior Event Free Survival In Classical Hodgkin Lymphoma

Hollander, Peter; Kamper, P.; Smedby, K. E.; Enblad, Gunilla et al.

Part of Haematologica, p. 1-2, 2016

Prognostic Implications Of An Active, Innate Or Anergic Immune Response In The Hodgkin Lymphoma Tumor Microenvironment

Hollander, Peter; Rostgaard, K.; Smedby, K. E.; Molin, Daniel et al.

Part of Haematologica, p. 3-3, 2016

Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma

Hollander, Peter; Rostgaard, Klaus; Smedby, Karin E.; Chang, Ellen T. et al.

Part of American Journal of Epidemiology, p. 624-632, 2015

• DOI for Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma

Epidemiology and prognosis in classical Hodgkin lymphoma

Hollander, Peter

2018

• Download full text (pdf) of Epidemiology and prognosis in classical Hodgkin lymphoma

PD-1 and PD-L1 are upregulated in paired consecutive biopsies with classical Hodgkin lymphoma

Hollander, Peter; Amini, Rose-Marie; Ginman, Beatrice; Enblad, Gunilla et al.

Accumulation of High-Risk Genetic Features after Chemoimmunotherapy: A Longitudinal Study in Mantle Cell Lymphoma

Nikkarinen, Anna; Almlöf, Jonas; Österroos, Albin; Ladenvall, Claes et al.

Impact of Clonal Hematopoiesis on Hematological Treatment Toxicity in Mantle Cell Lymphoma Patients

Nikkarinen, Anna; Selvin, Tove; Almlöf, Jonas; Österroos, Albin et al.

Comprehensive blood plasma proteomics identifies VSIG4 and CD169 as prospective biomarkers for high-risk of early relapse in mantle cell lymphoma

Nylund, Patrick; Selvin, Tove; Nikkarinen, Anna; Ly, Ann-Marie et al.